Red Sox Suddenly Linked To The Blockbuster Move Fans Wanted

As the Red Sox eye a deep playoff run, acquiring Mets' star Francisco Lindor could be the power move they need to solidify their lineup.

With the trade deadline closing in, the Red Sox have gone from interesting to impossible to ignore.

Boston is 51-48, sits three games over .500, and is bringing a 14-game winning streak into Tuesday night’s game against the Baltimore Orioles. That surge has pushed the Red Sox into the No.

3 American League Wild Card spot, given them a 1 1/2-game cushion over the Texas Rangers for the final playoff position in the league, and left them just one game behind the Cleveland Guardians for the No. 2 Wild Card spot.

The standings are only part of the story. Boston is one of just six teams in the American League above .500, and its +46 run differential is third-best in the league, trailing only the New York Yankees at +88 and the Chicago White Sox at +52. The Red Sox have played their way into real contention, and the next step may be adding another bat in the middle of the order.

That’s where Francisco Lindor enters the conversation.

The Mets shortstop has been floated as a possible trade chip, and ESPN’s Kiley McDaniel and Jeff Passan gave the idea a little more oxygen on Tuesday by listing Boston among Lindor’s “best fits.”

"No. 12.

Francisco Lindor, SS, New York Mets," McDaniel and Passan wrote. "Chance of being traded: 15 percent.

Rest-of-season impact: High. Years of control: Five more years after 2026, at $32 million a year.

"The buzz: Like many on this list in front of him, Lindor is not likely to go anywhere at the deadline. Given the size of his contract - larger than any other available and desirable player's - his age (33 in November) and his full no-trade protection, a Lindor deal isn't exactly easy to pull off.

That doesn't mean it won't happen. ... Best fits: Blue Jays, Yankees, Red Sox, Braves."

SNY’s Chelsea Janes reported that the Mets have told teams that everyone but Carson Benge, A.J. Ewing, Christian Scott, Nolan McLean and Juan Soto is available. Lindor was not included in that group.

And that’s the catch here: the fit makes sense, but the deal would be a monster to execute. Lindor has a no-trade clause, and he’s still owed just over $32 million per year for the next five seasons. That kind of contract narrows the path fast.

Still, Boston has already shown it’s willing to make a move nobody saw coming. Last year, the Red Sox dealt Rafael Devers - along with his massive contract - to the San Francisco Giants in a pre-deadline trade. Craig Breslow has already proven he’s not scared of a bold swing.

Lindor’s track record is exactly why his name keeps surfacing. From 2022 through 2025, he never finished a season with fewer than 5.4 wins above replacement, and in that same span he never hit fewer than 26 home runs or drove in fewer than 86 runs. He has had injury issues this year, and that has dragged down his offensive numbers, but he’s healthy now and starting to look like himself again.

He’s 32, he’s been regarded as a strong clubhouse presence throughout his career, and he would give Boston the kind of middle-of-the-order punch that could change the look of this lineup. It may be a long shot, but the Red Sox should at least make the call and find out what the Mets would want.

In Other News...

Mets Already Have One Costly Problem Getting Harder To Escape

Bo Bichettes first season in Queens has not gone the way the Mets hoped when they brought him in on a three-year deal, and the early returns have only made the next few winters more complicated. His contract includes player opt-outs after the 2026 and 2027 seasons, a structure that gives him flexibility but also leaves the Mets with a tricky piece to manage if they ever decide the fit is no longer right.

The on-field performance has only added to the concern. Bichette is hitting .253 with a .670 OPS, numbers that sit well below his usual standard and make any future move harder to envision. For a team that already knows how difficult it can be to navigate expensive roster decisions, this is the kind of problem that tends to linger until someone finds a reason to take it off the board. [Read more 🡒]

Freddy Peralta Just Reopened A Frustrating Mets Debate About Stearns

Freddy Peraltas rough night in Milwaukee did more than dent his own numbers. It also nudged an old Mets conversation back into view, the one about how aggressively David Stearns should chase starting pitching and how much faith the club should place in arms that come with real upside but real risk. Peralta has not looked like the kind of front-line stopper teams dream on, and his season has only added fuel to the idea that the gap between a good starter and a true ace is a lot wider than it looks on paper.

For the Mets, that is the uncomfortable part. Stearns has been open to making moves, but the organization has still drawn a line when it comes to pricey long-term commitments for pitchers, even when the market keeps pushing clubs toward them. Peraltas latest outing did not settle the debate, but it did sharpen it again, because the question is not whether the Mets need more pitching help. It is whether the kind they have been reluctant to buy is exactly the kind they keep ending up needing. [Read more 🡒]

Surprising Mets All-Star Trade Idea Could Split Fans Fast

As the Aug. 3 trade deadline approaches, San Diego is still looking for ways to bolster its pitching staff, and a recent proposal from former MLB general manager Jim Bowden has put an unexpected Mets angle into the conversation. The idea would send prospect Kash Mayfield to New York in exchange for Freddy Peralta, a move built around the belief that the right-hander could still be a useful bounce-back arm and give the Padres needed depth for the stretch run.

Peraltas season has been uneven enough to make any pursuit feel risky, which is why the proposal has already the kind of split-fan energy that usually follows a deadline rumor. For the Mets, it would mean weighing the value of a young arm against the chance to add a pitcher with a track record that still carries real appeal, even if this year has made the market more complicated than it looked a few months ago. [Read more 🡒]